Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | S-92-024 |
Topic: | Treatment of Acne |
Section: | Surgery |
Effective Date: | July 30, 2018 |
Issue Date: | July 30, 2018 |
Last Reviewed: | February 2018 |
Acne is a common, inflammatory disease of the sebaceous glands characterized by comedones, papules, pustules, inflamed nodules, and superficial pus-filled cysts. Acne occurs when sebum blocks the sebaceous glands and adjacent hair follicles. This blockage allows bacteria to multiply and inflame the blocked hair follicle. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Surgical treatment of acne may be considered medically necessary for marsupialization, opening, expression, removal of comedones, milia and pustules, incision and drainage.
Surgical treatment of acne is considered not medically necessary for all other indications not listed above.
Laser treatment of active acne is considered experimental/investigational. Scientific evidence does not demonstrate the efficacy of lasers to treat acne.
Active acne is distinguished from acne scarring which results from tissue damage after the inflammatory phase subsides. Post acne surgery will be processed in accordance with the guidelines indicated on the cosmetic/reconstructive surgery policy.
Medical visits for the treatment of acne are covered under the appropriate Evaluation and Management service. Coverage for medical visits is determined according to individual or group customer benefits.
See Medical Policy Bulletin S-71 for information on Photodynamic Therapy. See Medical Policy Bulletin S-28 for information on cosmetic/reconstructive surgery. |
Place of Service: Outpatient |
Experimental/Investigational (E/I) services are not covered regardless of place of service.
The treatment of acne is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |
05/2018, Addition of Facility Logic for Treatment of Acne